ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.58
-0.02%
US Tech 100
20,309.20
-0.31%
S&P 500
6,021.63
0.57%
US Dollar vs CAD
1.405
-0.03%
Bitcoin
93,407.93
1.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Pathfinder Cell Therapy Inc (CE) (PFND)

  7. Pathfinder Cell Therapy Inc (CE) (PFND) News

PFND

Pathfinder Cell Therapy (CE) (PFND)

Pathfinder Cell Therapy Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PFND
DateTimeSourceHeadlineSymbolCompany
04/05/20165:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/30/20163:16PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/20164:26PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/20162:26PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:40PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:37PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:37PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:35PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:32PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/20165:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/20165:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/16/20169:59AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/16/20169:56AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
12/04/20159:04AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
11/13/201510:23AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
11/04/20159:21AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
10/07/20158:19AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
09/01/20151:12PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
08/18/201511:20AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
08/13/201511:14AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
07/20/201511:56AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
06/09/20152:24PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
05/15/20157:09AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/31/201511:19AMEdgar (US Regulatory)Annual Report (10-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/06/20151:55PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
02/03/20153:11PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
12/31/20149:25AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
12/02/20147:56AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
11/14/201412:11PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
10/28/201410:33AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
 Showing the most relevant articles for your search:USOTC:PFND

Your Recent History

BIT
S27845
Societe Generale Effekten
BOV
C1NC34R
Centene
TSXV
BPLI
BPLI
USOTC
PNXP
Pineapple Express Cannabis (PK)
USOTC
SRRPF
Shagrir Group Vehicle Se... (CE)
LSE
TRS5
Spdr 3-7 $trs
BOV
BIYT39M
BlackRock Institutional ...
USOTC
CZNL
Citizens National (PK)
BIT
P1KOK0
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68